BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 7, 2016
View Archived Issues
CombiMatrix launches preimplantation genetic diagnosic test CombiPGD
Read More
Pfizer and Allergan announce termination of proposed merger agreement
Read More
Kamada initiates phase II study with intravenous alpha1-antitrypsin
Read More
Regeneron and MedImmune enter agreement to develop ADCs for the treatment of cancer
Read More
Bayer Schering Pharma patents factor XIa and KLKB1 inhibitors
Read More
AbbVie discloses HAT inhibitors
Read More
Ironwood Pharmaceuticals describes sGC activators
Read More
FORMA Therapeutics develops mutant-isocitrate dehydrogenase inhibitors
Read More
Epizyme presents lysine-specific demethylase inhibitors
Read More
Janssen and Tesaro announces global prostate cancer collaboration
Read More
PSMA1 shows potential as a prognostic biomarker for colon cancer
Read More
FDA grants orphan drug designation to 9-ING-41 for the treatment of glioblastoma
Read More
BIND Therapeutics reports topline data from phase II iNSITE 1 and 2 trials
Read More
Bristol-Myers Squibb's Opdivo approved in new indication in E.U.
Read More
TCF3 may be a useful biomarker to discriminate between seminomatous and non-seminomatous GCTs
Read More
MorphoSys and Galapagos begin clinical trials of MOR-106
Read More
Peptidream announces research agreement with BIND Therapeutics
Read More
Alpha Cancer's AFP assets for oncology and autoimmune diseases
Read More
SanBio cleared in Japan to conduct phase II trial of stem cell therapy
Read More
Pasireotide lowers plasma ACTH levels in patients with Nelson's syndrome
Read More
Allergan and Heptares announce commercialization agreement for novel neurologic disease therapies
Read More
Novartis' Revolade now approved for pediatric patients in E.U.
Read More
Afatinib approved in Europe for squamous cell carcinoma of the lung
Read More
Dako launches test for nivolumab survival benefit in non-squamous NSCLC
Read More